APSR2026-384

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-006
P61
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1219999-46904-Poster %23APSR2026-384_429845.pdf
Format: PDF Only
06. Tuberculosis
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Angelica Gabrielle Sy * Metropolitan Medical Center Internal Medicine Manila Philippines
Myra Tan - Metropolitan Medical Center Internal Medicine Manila Philippines
Samson Tan - Metropolitan Medical Center Internal Medicine Manila Philippines
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Angelica Gabrielle
Sy
angelicagabrielle.md@gmail.com
+639088960932
31-40
Philippines
Original Research
Treatment Outcomes of Tuberculosis patients at Metropolitan Medical Center (Tertiary Hospital) Public-Private Mixed TB DOTS from January 2017 to December 2024: A cross-sectional study
Maximum 25 words
Abstract Content
Tuberculosis remains to be a major global public health threat and the TB DOTS and its public-private mix (PPM) component is a cornerstone strategy against the disease. Metropolitan Medical Center (MMC) has been participating as a PPM-DOTS since 2017. However, a systematic evaluation of its long-term performance has not been conducted. This study determined the treatment outcomes of the TB patients enrolled at the MMC PPM-DOTS from 2017 to 2024.
This retrospective cross-sectional study reviewed all the enrolled MMC TB DOTS patient records from January 1, 2017 to December 31, 2024. Data on demographics, clinical characteristics type of TB, treatment category and treatment outcomes were analyzed using descriptive and inferential statistics.
The patient enrollment rate demonstrated a consistent growth, with majority of patients being male (60.4%) and part of the working age group of 18-59 years old. Most of the population were referrals from the private physicians of MMC (99.61%). Majority were clinically diagnosed (79.9%), with pulmonary TB being most predominant (97.97%). Successful treatment outcome was 74.78%, with a treatment completion rate of 74.4%. Unsuccessful treatment outcome (25.22%) was primarily due to loss to follow-up (23.3%). Of the variables in the study, bacteriologic and microbiologic testing (p<0.001) were found to be significantly associated with treatment outcome.
There is a growing impact of the private hospitals in TB management. While treatment completion was high, there are challenges in bacteriologic diagnosis and patient retention. To improve the TB DOTS program at MMC, expanding staff, ensuring steady drug supply, and enhancing communication and cooperation between private hospitals and the government.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Tuberculosis Directly Observed Treatment, Retrospective study, Private-public mix
maximum 3 keywords and no abbreviations, separated by commas
 
267